EPHB2 and glioblastoma: A cytotoxic fusion protein based on ephrin-A5, which targets EphA3, EphA2, and EphB2, selectively kills GBM cells with remarkable potency (IC50 ≈ 10−11 M; Ferluga et al., 2016).